0
0

Therapeutic Fraud Prevention Act of 2021

12/30/2022, 1:18 PM

Congressional Summary of S 2242

Therapeutic Fraud Prevention Act of 2021

This bill prohibits commercial conversion therapy, which is a practice or treatment designed to change a person's sexual orientation or gender identity or otherwise change behaviors, thoughts, or expressions related to gender or sexual attraction. This prohibition does not apply to treatment that assists an individual undergoing a gender transition or facilitates identity exploration and development.

Current Status of Bill S 2242

Bill S 2242 is currently in the status of Bill Introduced since June 24, 2021. Bill S 2242 was introduced during Congress 117 and was introduced to the Senate on June 24, 2021.  Bill S 2242's most recent activity was Read twice and referred to the Committee on Commerce, Science, and Transportation. as of June 24, 2021

Bipartisan Support of Bill S 2242

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
42
Democrat Cosponsors
40
Republican Cosponsors
0
Unaffiliated Cosponsors
2

Policy Area and Potential Impact of Bill S 2242

Primary Policy Focus

Commerce

Potential Impact Areas

- Civil actions and liability
- Consumer affairs
- Marketing and advertising
- Mental health
- Sex and reproductive health
- Sex, gender, sexual orientation discrimination
- Social work, volunteer service, charitable organizations
- State and local government operations

Alternate Title(s) of Bill S 2242

Therapeutic Fraud Prevention Act of 2021
A bill to prohibit commercial sexual orientation conversion therapy, and for other purposes.
Therapeutic Fraud Prevention Act of 2021

Comments